Anna Protopapas's Net Worth
Anna Protopapas's net worth is estimated to be at least $1,070,773.56 as of 11/23/2024. CoreStreet's estimation of Anna Protopapas's net worth is based on their sale of stock and current holding of stock.
Anna Protopapas is Director at Mersana Therapeutics Inc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 29,399 units of MRSN stock on 01/16/2024. Their biggest sale was on 12/18/2023 when they sold 5,000 units of Nuvalent Inc stock for $378,350.00. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $1,070,773.56
Most recent insider trade:
- Jan. 16, 2024
Anna Protopapas's Insider Trading History
| Mersana Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 16, 2024 | Director | 29,399 | $2.71 | Sell | $79,671.29 |
Jan. 17, 2023 | CEO | 17,346 | $5.74 | Sell | $99,566.04 |
July 19, 2021 | CEO | 21,901 | $12.02 | Sell | $263,250.02 |
July 16, 2021 | CEO | 20,043 | $12.47 | Sell | $249,936.21 |
| Nuvalent Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 18, 2023 | Director | 5,000 | $75.67 | Sell | $378,350.00 |